The Cost of Type II Diabetes Mellitus: A Machine Learning Perspective

2016 ◽  
pp. 824-827 ◽  
Author(s):  
Ghazaal Sheikhi ◽  
Hakan Altınçay
Keyword(s):  
Diabetes Mellitus ◽  
Machine Learning ◽  
Type Ii Diabetes ◽  
Type Ii Diabetes Mellitus ◽  
Type Ii ◽  
The Cost

scholarly journals EFFECT OF TARAKESWARA RASA IN MICROALBUMINURIA ASSOCIATED WITH TYPE (II) DIABETES MELLITUS - A CLINICAL STUDY

2021 ◽  
Vol p5 (02) ◽  
pp. 2671-2679
Author(s):  
Krishnaveni. R ◽  
Jacob. M. Titus ◽  
Sreeni T.V.
Keyword(s):  
Diabetes Mellitus ◽  
Kidney Disease ◽  
Type Ii Diabetes ◽  
Diabetic Kidney Disease ◽  
Study Drug ◽  
Type Ii Diabetes Mellitus ◽  
Diabetic Patients ◽  
Type Ii ◽  
Diabetic Kidney ◽  
The Cost

Microalbuminuria associated with Type (II) Diabetes mellitus is a strong predictor of upcoming Diabetic Nephropathy. It is a major cause of Diabetic kidney disease, leading to mortality and morbidity in these patients. The cost of treatment in a Diabetic kidney disease is huge; the cost may further escalate unless prevention and intervention are initiated at an earlier stage, which would help in minimizing further com-plications. The current treatment modalities of ACE inhibitors and RAS blockades alone cannot support this disease. Ayurveda with its array of herbal and mineral medicines has been used for managing this dis-ease and its complications. Tarakeswara Rasa is one such formulation used in managing Diabetes. It is a herbo-mineral formulation containing Rasasindoora, Loha, Vanga and Abraka Bhasmas each of which are potent Rasa Rasayana’s used in treating Diabetes. The study drug was meticulously prepared and analyzed for XRD, XRF, PSA etc. An interventional study was conducted for evaluating the effect of Tarakeswara Rasa in 20 Type (II) Diabetic patients having Microalbumin from 30-300mg/g. Tarakeswara rasa with a dosage of 125mg was administered twice daily with honey and Udumbaraphala (fig’s) 3g as Anupana (ve-hicle). The patients were asked to follow a strict diet and exercise regimen for a period of 1 month. The outcome variables such as level of Microalbumin in urine, FBS, PPBS, HbA1c, Urinary sugar and albumin, Blood Pressure and Serum cholesterol were analyzed using paired ‘t’ test and symptomatic change ana-lyzed before and after treatment using Wilcoxon signed rank test. The results showed that, the study drug Tarakeswara Rasa is effective in managing Microalbuminuria associated with Type (II) Diabetes Mellitus supported by laboratory findings and also improves the overall quality of life of Diabetic patients.

Cost-effectiveness of Bariatric Surgery: Increasing the Economic Viability of the Most Effective Treatment for Type II Diabetes Mellitus

2015 ◽  
Vol 81 (8) ◽  
pp. 807-811 ◽  
Author(s):  
Jeremy A. Warren ◽  
Joseph A. Ewing ◽  
Allyson L. Hale ◽  
Dawn W. Blackhurst ◽  
Eric S. Bour ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Bariatric Surgery ◽  
Cost Effectiveness ◽  
Type Ii Diabetes ◽  
Cost Savings ◽  
Medical Costs ◽  
Type Ii Diabetes Mellitus ◽  
Morbidly Obese ◽  
Type Ii ◽  
The Cost

There has been considerable debate on the cost-effectiveness of bariatric surgery within larger population groups. Despite the recognition that morbid obesity and its comorbidities are best treated surgically, insurance coverage is not universally available. One of the more costly comorbidities of obesity is Type II diabetes mellitus (T2DM). We propose a model that demonstrates the cost-effectiveness of increasing the number of bariatric surgical operations performed on patients with T2DM in the United States. We applied published population cost estimates (2012) for medical care of T2DM to a retrospective cohort of morbidly obese patients in South Carolina. We compared differences in 10-year medical costs between those having bariatric surgery and controls. Resolution of T2DM in the bariatric cohort was assumed to be 40 per cent. Considering only the direct medical costs of T2DM, the 10-year aggregate cost savings compared with a control group is $2.7 million/1000 patients; the total (direct and indirect) cost savings is $5.4 million/1000 patients. When considering resolution of T2DM alone, increasing the number of bariatric operations for a given population leads to a substantial cost savings over a 10-year period. This study adds to the growing body of evidence suggesting that bariatric surgery is a cost-effective means of caring for the obese patient.

scholarly journals Economic Burden of Hypoglycaemia among Type II Diabetes Mellitus Patients in Malaysia

2019 ◽  
Author(s):  
Syed Mohamed Aljunid ◽  
Yin New Aung ◽  
Aniza Ismail ◽  
Siti Athirah Zafirah Abdul Rashid ◽  
Amrizal M Nur ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Economic Burden ◽  
Type Ii Diabetes ◽  
Type Ii Diabetes Mellitus ◽  
Primary Diagnosis ◽  
Cost Of Care ◽  
Type Ii ◽  
Health Providers ◽  
Cross Sectional ◽  
The Cost

AbstractObjectiveThe main aim of this study is to identify the direct cost and economic burden of hypoglycaemia among patients with Type II diabetes mellitus in Malaysia.MethodsThe incurred cost for hypoglycaemia among patients admitted to University Kebangsaan Malaysia Medical Centre (UKMMC) was explored from a cross sectional study. 20-79 year patients discharged between Jan 2010 to Sept 2015 and having an ICD-10 code of hypoglycaemia as a primary diagnosis in the casemix database were included in the study. Costing analysis from the perspective of health providers was completed using step-down approach. Data related to hospital cost were collected using hospital-costing template, based on three levels of cost centres. The costing data from UKMMC was used to estimate the national burden of hypoglycaemia among type II diabetics for the whole country.ResultsOf 244 diabetes patients admitted primarily for hypoglycaemia to UKMMC, 52% were female and 88% were over 50 years old. The cost increased with severity. Managing a hypoglycaemic case requires 5 days (median) of inpatient stay with a range of 2-26 days; and costs RM 9,083 (USD 2,323). 30% of the cost came from the ward services cost (final cost centre), 16% of the cost came from ICU services and 15% from pharmacy services(secondarylevel cost centres). Based on the prevalence of hypoglycaemia-related admissions of 3.2%, the total cost of care for hypoglycaemia among adult diabetes in Malaysia is estimated to be RM 117.4 (USD 30.0) million, which is translated as 0.5% of Ministry of Health budget.ConclusionHypoglycaemia imposes substantial economic impact even without the direct and indirect cost incurred by patients and other cost of complications. Proper diabetic care and health education is needed in diabetic management to reduce episodes of hypoglycaemia.

Sign in / Sign up

Export Citation Format

Share Document